药物信息为ALDURAZYME (laronidase) Solution for intravenous infusion only (Genzyme Corporation): WARNING: RISK OF ANAPHYLAXIS
- WARNING: RISK OF ANAPHYLAXIS
- 1 INDICATIONS AND USAGE
- 3 DOSAGE FORMS AND STRENGTHS
- 4 CONTRAINDICATIONS
- 7 DRUG INTERACTIONS
- 10 OVERDOSAGE
- 11 DESCRIPTION
- 14 CLINICAL STUDIES
- 16 HOW SUPPLIED/STORAGE AND HANDLING
- 17 PATIENT COUNSELING INFORMATION
- PACKAGE LABEL
- 外部链接相关的ALDURAZYME (laronidase) Solution for intravenous infusion only (Genzyme Corporation)
Life-threatening anaphylactic reactions have been observed in some patients during ALDURAZYME® infusions. Therefore, appropriate medical support should be readily available when ALDURAZYME is administered. Patients with compromised respiratory function or acute respiratory disease may be at risk of serious acute exacerbation of their respiratory compromise due to infusion reactions, and require additional monitoring.
- Drug Information Provided by National Library of Medicine (NLM).
